Funder
National Natural Science Foundation of China
Natural Science Youth Foundation of Nanjing University of Chinese Medicine
Medical Scientific Research Project of Jiangsu Provincial Health Commission
Outstanding Youth Fund Project of Nanjing Health Science and Technology Development
Traditional Chinese Medicine Youth Talent Training Program of Nanjing
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology,General Medicine
Reference39 articles.
1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer j clini. 2021;71:209–49.
2. Galle PR, Dufour J, Peck-Radosavljevic M, et al. Systemic therapy of advanced hepatocellular carcinoma. Future Oncol. 2021;17:1237–51.
3. Huang A, Yang XR, Chung WY, et al. Targeted therapy for hepatocellular carcinoma. Signal Transduct Target Ther. 2020;5:146.
4. Assenat E, Pageaux G, Thézenas S, et al. Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial. Br j cancer. 2019;120:896–902.
5. Gauthier A, Ho M. Role of sorafenib in the treatment of advanced hepatocellular carcinoma: an update. Hepatol Res. 2013;43:147–54.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献